These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24613412)

  • 61. Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
    Kotini AG; Carcamo S; Cruz-Rodriguez N; Olszewska M; Wang T; Demircioglu D; Chang CJ; Bernard E; Chao MP; Majeti R; Luo H; Kharas MG; Hasson D; Papapetrou EP
    Blood Cancer Discov; 2023 Jul; 4(4):318-335. PubMed ID: 37067914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An Experimental and Computational Protocol to Study Cell Proliferation in Human Acute Myeloid Leukemia Xenografts.
    Vlachou T; Nobile MS; Ronchini C; Besozzi D; Pelicci PG
    Methods Mol Biol; 2021; 2185():241-258. PubMed ID: 33165852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
    Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
    J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemia.
    Walter C; Pozzorini C; Reinhardt K; Geffers R; Xu Z; Reinhardt D; von Neuhoff N; Hanenberg H
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090521
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia.
    Preuner S; Mitterbauer G; Mannhalter C; Herndlhofer S; Sperr WR; Valent P; Lion T
    Eur J Cancer; 2012 Jan; 48(2):233-6. PubMed ID: 21955823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
    Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
    Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutation position within evolutionary subclonal architecture in AML.
    Welch JS
    Semin Hematol; 2014 Oct; 51(4):273-81. PubMed ID: 25311740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dissecting Clonal Heterogeneity in AML.
    Schuringa JJ; Bonifer C
    Cancer Cell; 2020 Dec; 38(6):782-784. PubMed ID: 33321087
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
    Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A robust xenotransplantation model for acute myeloid leukemia.
    Sanchez PV; Perry RL; Sarry JE; Perl AE; Murphy K; Swider CR; Bagg A; Choi JK; Biegel JA; Danet-Desnoyers G; Carroll M
    Leukemia; 2009 Nov; 23(11):2109-17. PubMed ID: 19626050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Minimal/Measurable Residual Disease Monitoring in
    Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with
    Martínez-Losada C; Serrano-López J; Serrano-López J; Noguera NI; Garza E; Piredda L; Lavorgna S; Consalvo MAI; Ottone T; Alfonso V; Peinado JR; Garcia-Ortiz MV; Morales-Ruiz T; Jérez A; Hurtado AM; Montesinos P; Cervera J; Such E; Ibañez M; Sempere A; Sanz MÁ; Lo-Coco F; Sánchez-García J
    Haematologica; 2018 Sep; 103(9):e400-e403. PubMed ID: 29622659
    [No Abstract]   [Full Text] [Related]  

  • 74. Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis.
    Bashey A; Gill R; Levi S; Farr CJ; Clutterbuck R; Millar JL; Pragnell IB; Marshall CJ
    Blood; 1992 Feb; 79(4):981-9. PubMed ID: 1737106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
    Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
    Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
    Chen X; Zhu H; Qiao C; Zhao S; Liu L; Wang Y; Jin H; Qian S; Wu Y
    Hematology; 2021 Dec; 26(1):111-122. PubMed ID: 33491606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The origin and evolution of mutations in acute myeloid leukemia.
    Welch JS; Ley TJ; Link DC; Miller CA; Larson DE; Koboldt DC; Wartman LD; Lamprecht TL; Liu F; Xia J; Kandoth C; Fulton RS; McLellan MD; Dooling DJ; Wallis JW; Chen K; Harris CC; Schmidt HK; Kalicki-Veizer JM; Lu C; Zhang Q; Lin L; O'Laughlin MD; McMichael JF; Delehaunty KD; Fulton LA; Magrini VJ; McGrath SD; Demeter RT; Vickery TL; Hundal J; Cook LL; Swift GW; Reed JP; Alldredge PA; Wylie TN; Walker JR; Watson MA; Heath SE; Shannon WD; Varghese N; Nagarajan R; Payton JE; Baty JD; Kulkarni S; Klco JM; Tomasson MH; Westervelt P; Walter MJ; Graubert TA; DiPersio JF; Ding L; Mardis ER; Wilson RK
    Cell; 2012 Jul; 150(2):264-78. PubMed ID: 22817890
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Single-Cell Sequencing Reveals Clonal Architecture of Myeloid Cancers.
    Cancer Discov; 2021 Jan; 11(1):13. PubMed ID: 33158845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.
    Bochtler T; Fröhling S; Krämer A
    Leukemia; 2015 Jun; 29(6):1243-52. PubMed ID: 25673237
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome.
    Saida S; Watanabe K; Sato-Otsubo A; Terui K; Yoshida K; Okuno Y; Toki T; Wang R; Shiraishi Y; Miyano S; Kato I; Morishima T; Fujino H; Umeda K; Hiramatsu H; Adachi S; Ito E; Ogawa S; Ito M; Nakahata T; Heike T
    Blood; 2013 May; 121(21):4377-87. PubMed ID: 23482930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.